Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient severe visual loss after panretinal photocoagulation.

R C Kleiner1, M J Elman, R P Murphy

  • 1Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, Maryland.

American Journal of Ophthalmology
|September 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Angiogenic and Senescent T Lymphocytes in Ageing and Frailty.

The Journal of frailty & aging·2024
Same author

Improved adherence to hip fracture standards reduces mortality after hip fractures.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2023
Same author

The very small angle neutron scattering instrument at the National Institute of Standards and Technology.

Journal of applied crystallography·2022
Same author

Where Are They Now? Five-Year Career Trends in a Single Graduating Medical Class

Irish medical journal·2020
Same author

Key Service Improvements After the Introduction of an Integrated Orthogeriatric Service.

Geriatric orthopaedic surgery & rehabilitation·2019
Same author

Spastic ataxia associated with colour vision deficiency due to DDHD2 mutations.

European journal of neurology·2019
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
See all related articles

Severe but temporary vision loss occurred in seven diabetic patients after panretinal photocoagulation for proliferative diabetic retinopathy. Vision recovered in all patients within months, with most regaining near-pre-treatment visual acuity.

Area of Science:

  • Ophthalmology
  • Diabetic Retinopathy Research

Background:

  • Panretinal photocoagulation (PRP) is a standard treatment for proliferative diabetic retinopathy.
  • Understanding potential adverse effects of PRP is crucial for patient management.

Observation:

  • Seven patients with proliferative diabetic retinopathy experienced sudden, severe vision decline post-PRP.
  • Visual acuity dropped significantly, ranging from 5/200 to no light perception shortly after treatment.
  • In most cases, no clear ocular complications explained the profound visual loss.

Findings:

  • All seven patients demonstrated transient visual loss following PRP.
  • Vision recovery occurred over nine days to nine months.
  • Five patients regained visual acuity close to their baseline levels.

Related Experiment Videos

Implications:

  • Transient visual loss is a potential, albeit uncommon, complication of PRP for diabetic retinopathy.
  • Close monitoring and further investigation may be needed for patients experiencing sudden vision changes post-PRP.
  • This highlights the importance of discussing potential risks and benefits with patients undergoing PRP treatment.